Clinical Trial Update: A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) [Phase 1]

View source ↗

Summary

A Phase 1 study is evaluating the concentration of Bimzelx (bimekizumab) in mature breast milk in mothers receiving treatment, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis
• Hidradenitis Suppurativa
• Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• BIMZELX (BIMEKIZUMAB)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis | Phase 1 | Status: RECRUITING